BioSpace News Archive

Company Profile for Chronix Biomedical Inc.

Healthcare Trust of America, Inc. announced today that its board of directors issued a quarterly dividend of $0.305 per share of common stock.

After a nearly three-week long strike over better working conditions, including a demand to end to precarious work contracts and insufficient compensation, Unifor workers reject the Port Arthur Health Centre final offer.

Barbara Browning was named the 2018 New Adult Educator of the Year by the Indiana Association for Adult & Continuing Education (IAACE).

BIO President and CEO Jim Greenwood issued the following statement regarding the Opioid Addiction Action Plan Act, introduced yesterday in the Senate by Senators Heller (R-NV), Isakson (R-GA), and Menendez (D-NJ).

The Atlanta Journal-Constitution (AJC) publishes another in-depth national investigation that reveals chilling new details about doctors accused of sexually abusing patients.

Eli Lilly and Company will participate in the Bank of America Merrill Lynch 2018 Health Care Conference on Wednesday, May 16, 2018.

Teva Pharmaceutical Industries Ltd. announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE® (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).

The pharmaceutical industry has turned to field medical teams to handle managed care interactions

Stellar Biotechnologies, Inc. is announcing a one-for-seven reverse share split of its common shares.